Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT02234102
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Prof. Dr. med. Bernd Lemke
- Registry
-
NCT02234102
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT02234102. Non-randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Endoscopically guided laser ablation HeartLight system
- Lead sponsor
- Prof. Dr. med. Bernd Lemke
Record details
- Record id
cardio:ct-nct02234102- Content hash
5dac0c9a0fb9769de0219990a5da5a9c0868821f500bbd95de503dc4b5d6552e